Gene · 2865
Papers2,060
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,060
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unravelling the gut-lung axis: insights into microbiome interactions and Traditional Indian Medicine's perspective on optimal health. | FEMS Microbiol Ecol | 2023 | 37656879 | PubTator, text mining | PubMed |
| 2023 Vascular Research Initiatives Conference: Structural and Immune Cells in Vascular Disease. | JVS Vasc Sci | 2023 | 37649474 | PubTator, text mining | PubMed |
| Astragalus improves intestinal barrier function and immunity by acting on intestinal microbiota to treat T2DM: a research review. | Front Immunol | 2023 | 37638043 | PubTator, text mining | PubMed |
| Immunomodulatory effects of inulin and its intestinal metabolites. | Front Immunol | 2023 | 37638034 | PubTator, text mining | PubMed |
| Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell. | Gut Microbes | 2023 | 37635362 | PubTator, text mining | PubMed |
| Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition. | Nutrients | 2023 | 37630759 | PubTator, text mining | PubMed |
| New Therapeutics for Heart Failure: Focusing on cGMP Signaling. | Int J Mol Sci | 2023 | 37629047 | PubTator, text mining | PubMed |
| Mediterranean Diet and Airway Inflammation in School-Aged Children. | Children (Basel) | 2023 | 37628304 | PubTator, text mining | PubMed |
| Recent Advances in Microbiota-Associated Metabolites in Heart Failure. | Biomedicines | 2023 | 37626809 | PubTator, text mining | PubMed |
The entero-endocrine response following a mixed-meal tolerance test with a non-nutritive pre-load in participants with pre-diabetes and type 2 diabetes: A crossover randomized controlled trial proof of concept study. | PLoS One | 2023 | 37624823 | PubTator, text mining | PubMed |
| Gut feelings in the islets: The role of the gut microbiome and the FFA2 and FFA3 receptors for short chain fatty acids on β-cell function and metabolic regulation. | Br J Pharmacol | 2023 | 37620991 | PubTator, text mining | PubMed |
| The roles and applications of short-chain fatty acids derived from microbial fermentation of dietary fibers in human cancer. | Front Nutr | 2023 | 37614742 | PubTator, text mining | PubMed |
| The role of short-chain fatty acids produced by gut microbiota in the regulation of pre-eclampsia onset. | Front Cell Infect Microbiol | 2023 | 37600950 | PubTator, text mining | PubMed |
| The gut microbiota-brain axis in neurological disorder. | Front Neurosci | 2023 | 37600019 | PubTator, text mining | PubMed |
| The effects of acarbose treatment on cardiovascular risk factors in impaired glucose tolerance and diabetic patients: a systematic review and dose-response meta-analysis of randomized clinical trials. | Front Nutr | 2023 | 37599681 | PubTator, text mining | PubMed |
| Short-chain fatty acids in diseases. | Cell Commun Signal | 2023 | 37596634 | PubTator, text mining | PubMed |
| The role of gut microbiome in the complex relationship between respiratory tract infection and asthma. | Front Microbiol | 2023 | 37577440 | PubTator, text mining | PubMed |
| Plant-Based Dietary Fibers and Polysaccharides as Modulators of Gut Microbiota in Intestinal and Lung Inflammation: Current State and Challenges. | Nutrients | 2023 | 37571257 | PubTator, text mining | PubMed |
| Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy. | Int J Mol Sci | 2023 | 37569625 | PubTator, text mining | PubMed |
| Microbial Reprogramming in Obsessive-Compulsive Disorders: A Review of Gut-Brain Communication and Emerging Evidence. | Int J Mol Sci | 2023 | 37569349 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2865/papers?page=15